TNF-Related Apoptosis Inducing Ligand in Ocular Cancers and Ocular Diabetic Complications

Figure 1

Synergic therapeutic approaches between TRAIL and chemotherapeutic drugs on rhabdomyosarcoma (RMS). Antitumor therapies based on the combination of standard chemotherapy with TRAIL treatment can lead to improved RMS cell apoptosis and/or to the overcoming of chemotherapy resistance. TRAIL-R, TRAIL receptors.